Literature DB >> 10196257

Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent.

R E Sutton1, M J Reitsma, N Uchida, P O Brown.   

Abstract

Human immunodeficiency virus (HIV) type 1 vectors are highly efficient in their ability to transduce human progenitor hematopoietic stem cells (PHSC). Although mitosis was not required for transduction of these cells, transduction rates were much greater once cells had been cultured in the presence of cytokines. Transduction rates, however, rarely exceeded 70%. We demonstrate here that there is a distinct subpopulation that is more easily transduced by HIV vectors. These cells were distinguished by a disproportionate population in the S/G2/M phases of the cell cycle. By sorting them prior to transduction, we found that those cells in either the G1 or S/G2/M fraction were more readily transduced than G0 cells. Maintaining the cells in G0 by omitting cytokines from the medium reduced transduction rates by up to 10-fold. Addition of cytokines to the medium immediately after transduction did not improve the transduction efficiency as measured by expression of the transgene. Analysis of replication intermediates indicated that the block to transduction of G0 cells operated near the time of initiation of reverse transcription. These results suggest that although lentivirus vectors can transduce nondividing PHSC, transduction efficiency is severalfold greater once the cells exit G0 and enter G1. Further characterization of these more transducible cells and identification of the cellular factors responsible may enhance transduction while maintaining the pluripotentiality of the PHSC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196257      PMCID: PMC104140     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA.

Authors:  H E Varmus; T Padgett; S Heasley; G Simon; J M Bishop
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

Review 2.  HIV-1 auxiliary proteins: making connections in a dying cell.

Authors:  B R Cullen
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

3.  Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses.

Authors:  E F Fritsch; H M Temin
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

4.  Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line.

Authors:  P Corbeau; G Kraus; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells.

Authors:  R E Sutton; H T Wu; R Rigg; E Böhnlein; P O Brown
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G.

Authors:  R K Akkina; R M Walton; M L Chen; Q X Li; V Planelles; I S Chen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site?

Authors:  R Schlegel; T S Tralka; M C Willingham; I Pastan
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

8.  Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle.

Authors:  J A Zack; A M Haislip; P Krogstad; I S Chen
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

10.  HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells.

Authors:  N Uchida; R E Sutton; A M Friera; D He; M J Reitsma; W C Chang; G Veres; R Scollay; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

View more
  42 in total

1.  In vivo assessment of gene delivery to keratinocytes by lentiviral vectors.

Authors:  Ulrich Kuhn; Atsushi Terunuma; Wolfgang Pfutzner; Ruth Ann Foster; Jonathan C Vogel
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells.

Authors:  H Mikkola; N B Woods; M Sjögren; H Helgadottir; I Hamaguchi; S E Jacobsen; D Trono; S Karlsson
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes.

Authors:  Michael D Mühlebach; Isabel Schmitt; Stefanie Steidl; Jörn Stitz; Matthias Schweizer; Thomas Blankenstein; Klaus Cichutek; Wolfgang Uckert
Journal:  J Mol Med (Berl)       Date:  2003-10-24       Impact factor: 4.599

4.  Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway.

Authors:  René Daniel; James G Greger; Richard A Katz; Konstantin D Taganov; Xiaoyun Wu; John C Kappes; Anna Marie Skalka
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain.

Authors:  Andre Larochelle; Jennifer M Gillette; Ronan Desmond; Brian Ichwan; Amy Cantilena; Alexandra Cerf; A John Barrett; Alan S Wayne; Jennifer Lippincott-Schwartz; Cynthia E Dunbar
Journal:  Blood       Date:  2012-01-06       Impact factor: 22.113

Review 6.  Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.

Authors:  Cecilia Frecha; Camille Lévy; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

7.  Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins.

Authors:  Yoon-Sang Kim; Matthew M Wielgosz; Phillip Hargrove; Steven Kepes; John Gray; Derek A Persons; Arthur W Nienhuis
Journal:  Mol Ther       Date:  2010-04-06       Impact factor: 11.454

8.  AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.

Authors:  André Larochelle; Allen Krouse; Mark Metzger; Donald Orlic; Robert E Donahue; Simon Fricker; Gary Bridger; Cynthia E Dunbar; Peiman Hematti
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

9.  Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells.

Authors:  Dustin J Maxwell; Jesper Bonde; David A Hess; Sarah A Hohm; Ryan Lahey; Ping Zhou; Michael H Creer; David Piwnica-Worms; Jan A Nolta
Journal:  Stem Cells       Date:  2007-11-29       Impact factor: 6.277

10.  Transduction of terminally differentiated neurons by avian sarcoma virus.

Authors:  James G Greger; Richard A Katz; Konstantin Taganov; Glenn F Rall; Anna Marie Skalka
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.